Related by context. Frequent words. (Click for all words.) 53 Symphony tCGM 53 ourability 53 RXi Pharmaceutical Corporation 53 please visit www.avid.com 52 CompanyaEUR TM s 51 please visit www.mscsoftware.com 50 theability 49 andservices 49 notlimited 49 predictive diagnostics 49 abilityto 49 inflammatory autoimmune diseases 48 andfinancial 48 Mago ® 48 dans le cadre 48 Richard L. Bready 48 affecting Amarin 47 hospitals physicians homecare 47 http:/www.national.com 47 DSL.net s 47 iv unanticipated 47 ultimate recoverability 46 thereby negatively impacting 46 ofnew 46 www.airiq.com 46 andbusiness 46 #G/#G cellular 46 Vectren nonutility subsidiaries 46 transportation fractionation 46 Elron identifies potential 46 Capstone MicroTurbine 46 services visit www.sumtotalsystems.com 46 punctal plug 45 www.nicusa.com 45 NotifySync 45 www.zigbee.org 45 Neo Kidney Augment 45 TranSwitch indebtedness 45 theforward looking 45 Terremark filings 45 regarding Heska 45 Accounts payable accrued liabilities 45 Standardising 45 XEROX R 45 ADSI reliance 45 Refinancing Transactions 45 Angiotech discovers develops 45 http:/www.platts.com 44 risks anduncertainties 44 eGene 44 IEVM 44 By Lisa Eckelbecker 44 FINANCIAL CONDITION AND 44 aresubject 44 postretirement benefit obligations 44 isavailable 44 while SAVVIS ensures 44 Vertical Networks 44 externally sourced 44 risksand uncertainties 44 LYON France BUSINESS WIRE 44 www.norsat.com 44 products andservices 44 www.VictoriasSecret.com www.BathandBodyWorks.com wDr. Tod Cooperman 44 NanoSemiconductor Company 44 should consult NeurogesX 44 satellite telephones simplex 44 differ materiallyfrom 43 theseforward looking 43 CHDT SEC Filings 43 using BioSante patented 43 availability 43 Tracey Schelmetic 43 greatly simplifying 43 SANCTURA R 43 Silicon CMOS Photonics 43 Alnylam dependence 43 party VLSI fabrication 43 implantable glucose sensor 43 differmaterially 43 PolarPro 43 thepotential 43 xxii 43 MedCom USA Inc. 43 sequencing gene expression 43 surgical cryoablation 43 theCompany 43 http:/www.appliedbiosystems.com 43 delinquencies defaults 43 www.hexion.com 43 g h 43 successfully commercialize REOLYSIN 43 AZASITE 43 xiii 43 viii insufficient 43 vii 43 #,#,#,#,# [010] 43 www.cvgrp.com 43 looking statements.These 43 vi 42 obtaining regulatory approvals